Neonatal Drug Therapy Manual


Disclaimer: Official controlled document is the CHEO and Ottawa Hospital online copy. It is the responsibility of user to ensure that any paper copy version is the same as the online version before use.

Alternate Name(s): 
Original Date: 
May 2016
Revised Date: 
Feb 2024
  • Severe hypotension with poor response to other therapy / Shock
  • IV continuous infusion
    • Central line preferred
  • Usual dosage range: 0.01-0.4 mcg/kg/minute. Max recommended 1 mcg/kg/minute


Side Effects: 
  • CVS: arrhythmias, bradycardia, peripheral (digital) ischemia
  • Local: skin necrosis with extravasation
Parameters to Monitor: 
  • BP, HR
  • ECG
  • Peripheral perfusion
  • Site of injection
Reconstitution and Stability: 
  • Norepinephrine 1 mg/mL
    • Take 0.24 mL (0.24 mg) and add to 19.76 mL of D5W
    • Final concentration: 12 mcg/mL
  • Norepinephrine 1 mg/mL
    • Take 1 mL (1 mg) and add to 19 mL of D5W
    • Final concentration: 50 mcg/mL (central line only)

- Solutions Compatible: D5W, 0.9% NaCl, D5W/0.9%NaCl

- Y-site Compatible: dobutamine, dopamine, epinephrine, fentanyl, KCl (up to 40 mmol/L), furosemide, heparin, hydromorphone, meropenem, midazolam, milrinone, morphine, SMOF, TPN

- Incompatible: insulin, pantoprazole, sodium bicarbonate


- Lau E (Editor). Drug Handbook and Formulary - The Hospital for Sick Children.  Toronto; 2016

- Taketomo CK,Hodding JH, Kraus DM.  Pediatric Dosage Handbook 22nd Edition. Hudson: Lexi-Comp Inc.; 2015

- Evidence-based Practice for Improving Quality  (EPIQ) Recommendations on Hemodynamics, 2023


The information contained on this website is provided for informational purposes only, as a guide to assist physicians, nurses and other healthcare providers in deciding on the appropriate care required for a particular patient. At all times, physicians, nurses and other healthcare providers must exercise their independent clinical judgment, based on their knowledge, training and experience, taking into account the specific facts and circumstances of each patient, when deciding on the appropriate course of investigation and/or treatment to recommend in a particular clinical situation.

CHEO has made every effort to ensure that the information contained on this website is as current and accurate as possible. However, changes can occur due to ongoing research and the constant influx of new information. Where possible, hospitals and healthcare practitioners should verify the information before acting on it.

Reliance on any information in this website is at the user's own risk. CHEO is not responsible or liable for any harm, loss or other consequences from the use or misuse of the information on this website.